{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:30:35Z","timestamp":1791919835822,"version":"4.3.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,7,23]],"date-time":"2009-07-23T00:00:00Z","timestamp":1248307200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1471-2261-9-31","type":"journal-article","created":{"date-parts":[[2009,7,23]],"date-time":"2009-07-23T18:14:12Z","timestamp":1248372852000},"source":"Crossref","is-referenced-by-count":64,"title":["Lack of cardioprotection from subcutaneously and preischemic administered Liraglutide in a closed chest porcine ischemia reperfusion model"],"prefix":"10.1186","volume":"9","author":[{"given":"Jens","family":"Kristensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrik M","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Haubjerg","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten Toftegaard","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Maeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,23]]},"reference":[{"key":"252_CR1","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1001\/jama.298.2.194","volume":"298","author":"RE Amori","year":"2007","unstructured":"Amori RE, Lau J, Pittas AG: Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. JAMA. 2007, 298: 194-206. 10.1001\/jama.298.2.194.","journal-title":"JAMA"},{"key":"252_CR2","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1055\/s-2004-826175","volume":"36","author":"MA Nauck","year":"2004","unstructured":"Nauck MA: Glucagon-like peptide 1 (GLP-1) in the treatment of diabetes. Horm Metab Res. 2004, 36: 852-858. 10.1055\/s-2004-826175.","journal-title":"Horm Metab Res"},{"key":"252_CR3","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1001\/jama.287.19.2570","volume":"287","author":"JA Beckman","year":"2002","unstructured":"Beckman JA, Creager MA, Libby P: Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002, 287: 2570-2581. 10.1001\/jama.287.19.2570.","journal-title":"JAMA"},{"key":"252_CR4","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1055\/s-2004-826173","volume":"36","author":"B Ahren","year":"2004","unstructured":"Ahren B: GLP-1 and extra-islet effects. Horm Metab Res. 2004, 36: 842-845. 10.1055\/s-2004-826173.","journal-title":"Horm Metab Res"},{"key":"252_CR5","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2337\/diabetes.54.1.146","volume":"54","author":"AK Bose","year":"2005","unstructured":"Bose AK, Mocanu MM, Carr RD, Brand CL, Yellon DM: Glucagon-like peptide 1 can directly protect the heart against ischemia\/reperfusion injury. Diabetes. 2005, 54: 146-151. 10.2337\/diabetes.54.1.146.","journal-title":"Diabetes"},{"key":"252_CR6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10557-007-6030-6","volume":"21","author":"AK Bose","year":"2007","unstructured":"Bose AK, Mocanu MM, Carr RD, Yellon DM: Myocardial ischaemia-reperfusion injury is attenuated by intact glucagon like peptide-1 (GLP-1) in the in vitro rat heart and may involve the p70s6K pathway. Cardiovasc Drugs Ther. 2007, 21: 253-256. 10.1007\/s10557-007-6030-6.","journal-title":"Cardiovasc Drugs Ther"},{"key":"252_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1124\/jpet.104.073890","volume":"312","author":"LA Nikolaidis","year":"2005","unstructured":"Nikolaidis LA, Doverspike A, Hentosz T, Zourelias L, Shen YT, Elahi D, Shannon RP: Glucagon-like peptide-1 limits myocardial stunning following brief coronary occlusion and reperfusion in conscious canines. J Pharmacol Exp Ther. 2005, 312: 303-308. 10.1124\/jpet.104.073890.","journal-title":"J Pharmacol Exp Ther"},{"key":"252_CR8","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0196-9781(03)00108-6","volume":"24","author":"M Kavianipour","year":"2003","unstructured":"Kavianipour M, Ehlers MR, Malmberg K, Ronquist G, Ryden L, Wikstrom G, Gutniak M: Glucagon-like peptide-1 (7\u201336) amide prevents the accumulation of pyruvate and lactate in the ischemic and non-ischemic porcine myocardium. Peptides. 2003, 24: 569-578. 10.1016\/S0196-9781(03)00108-6.","journal-title":"Peptides"},{"key":"252_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.regpep.2007.10.001","volume":"146","author":"DP Sonne","year":"2008","unstructured":"Sonne DP, Engstrom T, Treiman M: Protective effects of GLP-1 analogues exendin-4 and GLP-1(9\u201336) amide against ischemia-reperfusion injury in rat heart. Regul Pept. 2008, 146: 243-249. 10.1016\/j.regpep.2007.10.001.","journal-title":"Regul Pept"},{"key":"252_CR10","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2337\/db08-1193","volume":"58","author":"MH Noyan-Ashraf","year":"2009","unstructured":"Noyan-Ashraf MH, Momen MA, Ban K, Sadi AM, Zhou YQ, Riazi AM, Baggio LL, Henkelman RM, Husain M, Drucker DJ: GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice. Diabetes. 2009, 58: 975-983. 10.2337\/db08-1193.","journal-title":"Diabetes"},{"key":"252_CR11","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jacc.2008.10.033","volume":"53","author":"L Timmers","year":"2009","unstructured":"Timmers L, Henriques JP, de Kleijn DP, Devries JH, Kemperman H, Steendijk P, Verlaan CW, Kerver M, Piek JJ, Doevendans PA, et al: Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury. J Am Coll Cardiol. 2009, 53: 501-510. 10.1016\/j.jacc.2008.10.033.","journal-title":"J Am Coll Cardiol"},{"key":"252_CR12","first-page":"E459","volume":"266","author":"JM Barragan","year":"1994","unstructured":"Barragan JM, Rodriguez RE, Blazquez E: Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7\u201336) amide in rats. Am J Physiol. 1994, 266: E459-E466.","journal-title":"Am J Physiol"},{"key":"252_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00125-001-0719-z","volume":"45","author":"H Agerso","year":"2002","unstructured":"Agerso H, Jensen LB, Elbrond B, Rolan P, Zdravkovic M: The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men. Diabetologia. 2002, 45: 195-202. 10.1007\/s00125-001-0719-z.","journal-title":"Diabetologia"},{"key":"252_CR14","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s00395-005-0574-z","volume":"101","author":"UM Mortensen","year":"2006","unstructured":"Mortensen UM, Norgaard BL, Nielsen-Kudsk JE, Kristensen J, Maeng M, Nielsen TT: A phase of increased ST elevation during coronary occlusion following ischemic preconditioning. Basic Res Cardiol. 2006, 101: 140-148. 10.1007\/s00395-005-0574-z.","journal-title":"Basic Res Cardiol"},{"key":"252_CR15","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.2337\/diacare.25.8.1398","volume":"25","author":"B Elbrond","year":"2002","unstructured":"Elbrond B, Jakobsen G, Larsen S, Agerso H, Jensen LB, Rolan P, Sturis J, Hatorp V, Zdravkovic M: Pharmacokinetics, pharmacodynamics, safety, and tolerability of a single-dose of NN2211, a long-acting glucagon-like peptide 1 derivative, in healthy male subjects. Diabetes Care. 2002, 25: 1398-1404. 10.2337\/diacare.25.8.1398.","journal-title":"Diabetes Care"},{"key":"252_CR16","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1161\/01.CIR.0000120505.91348.58","volume":"109","author":"LA Nikolaidis","year":"2004","unstructured":"Nikolaidis LA, Mankad S, Sokos GG, Miske G, Shah A, Elahi D, Shannon RP: Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion. Circulation. 2004, 109: 962-965. 10.1161\/01.CIR.0000120505.91348.58.","journal-title":"Circulation"},{"key":"252_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1161\/01.RES.0000137171.97172.d7","volume":"95","author":"R Bolli","year":"2004","unstructured":"Bolli R, Becker L, Gross G, Mentzer R, Balshaw D, Lathrop DA: Myocardial protection at a crossroads: the need for translation into clinical therapy. Circ Res. 2004, 95: 125-134. 10.1161\/01.RES.0000137171.97172.d7.","journal-title":"Circ Res"},{"key":"252_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10557-005-6892-4","volume":"19","author":"AK Bose","year":"2005","unstructured":"Bose AK, Mocanu MM, Carr RD, Yellon DM: Glucagon like peptide-1 is protective against myocardial ischemia\/reperfusion injury when given either as a preconditioning mimetic or at reperfusion in an isolated rat heart model. Cardiovasc Drugs Ther. 2005, 19: 9-11. 10.1007\/s10557-005-6892-4.","journal-title":"Cardiovasc Drugs Ther"},{"key":"252_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1146\/annurev.physiol.62.1.79","volume":"62","author":"MV Cohen","year":"2000","unstructured":"Cohen MV, Baines CP, Downey JM: Ischemic preconditioning: from adenosine receptor of KATP channel. Annu Rev Physiol. 2000, 62: 79-109. 10.1146\/annurev.physiol.62.1.79.","journal-title":"Annu Rev Physiol"},{"key":"252_CR20","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/00005344-200303000-00008","volume":"41","author":"C Frances","year":"2003","unstructured":"Frances C, Nazeyrollas P, Prevost A, Moreau F, Pisani J, Davani S, Kantelip JP, Millart H: Role of beta 1- and beta 2-adrenoceptor subtypes in preconditioning against myocardial dysfunction after ischemia and reperfusion. J Cardiovasc Pharmacol. 2003, 41: 396-405. 10.1097\/00005344-200303000-00008.","journal-title":"J Cardiovasc Pharmacol"},{"key":"252_CR21","volume-title":"PhD Thesis","author":"J Kristensen","year":"2006","unstructured":"Kristensen J: Experimental cardioprotection in myocardial ischemia and reperfusion assessed by sestamibi-MPI. PhD Thesis. 2006, Faculty of Health Science Aarhus, University of Aarhus"},{"key":"252_CR22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/00006231-200405000-00011","volume":"25","author":"J Kristensen","year":"2004","unstructured":"Kristensen J, Mortensen U, Nielsen SS, Maeng M, Nielsen TT, Rehling M: Myocardial perfusion imaging with 99mTc-sestamibi early after reperfusion reliably reflects infarct size reduction by ischemic precondtioning i an experimental porcine model. Nuclear Medicine Communications. 2004, 25: 495-500. 10.1097\/00006231-200405000-00011.","journal-title":"Nuclear Medicine Communications"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2261-9-31\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-9-31.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-9-31","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-9-31.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:13:08Z","timestamp":1548115988000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/1471-2261-9-31"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,23]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["252"],"URL":"https:\/\/doi.org\/10.1186\/1471-2261-9-31","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,23]]},"article-number":"31"}}